Tocilizumab in COVID-19 Lahore General Hospital
NCT04560205
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER_GOV
Sponsor class
Conditions
SARS-CoV Infection
Interventions
DRUG:
Tocilizumab
Sponsor
Lahore General Hospital